E-health tool identifies individuals at risk of opioid overdose

A psychoeducational tool identifies patients at risk for an opioid overdose but fails to motivate them to change their behavior. Findings are published in Cyberpsychology, Behavior, and Social Networking.

As the opioid epidemic continues, the number of individuals who overdose is increasing. In this study, researchers examined the effect the ORION (Overdose RIsk InfOrmatioN) e-health tool could have on opioid abuse patients' behavior.

The ORION program provides relevant information for opioid-dependent individuals regarding the risk in overdosing as a result of high-risk behavior. Researchers enrolled 194 opioid-dependent, treatment-seeking individuals from across Europe. Data were collected pre- and post-software use.

 Results showed the ORION system was able to identify individuals at the highest risk and most in need of reducing their risk behaviors, but the tool was not able to influence self-efficacy.

“Nonetheless, the ORION tool is unique in its style and content of delivery, that is translating risks combination into a clear estimation, and will need further development such as (a) integration in smartphone-based e-health apps and (b) testing in other high-risk populations,” concluded first author Giuseppe Carrà, MD, PhD, and colleagues.

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.